These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36689187)

  • 21. An efficient miRNA knockout approach using CRISPR-Cas9 in Xenopus.
    Godden AM; Antonaci M; Ward NJ; van der Lee M; Abu-Daya A; Guille M; Wheeler GN
    Dev Biol; 2022 Mar; 483():66-75. PubMed ID: 34968443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a miRNA Sensor by an Inducible CRISPR-Cas9 Construct in Ciona Embryogenesis.
    Wang Z; Sun X; Zhang X; Dong B; Yu H
    Mol Biotechnol; 2021 Jul; 63(7):613-620. PubMed ID: 33880702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR/Cas9-Mediated Hitchhike Expression of Functional shRNAs at the Porcine
    Lu C; Pang D; Li M; Yuan H; Yu T; Huang P; Li J; Chen X; Jiao H; Xie Z; Ouyang H
    Cells; 2019 Feb; 8(2):. PubMed ID: 30717310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo mutagenesis of miRNA gene families using a scalable multiplexed CRISPR/Cas9 nuclease system.
    Narayanan A; Hill-Teran G; Moro A; Ristori E; Kasper DM; A Roden C; Lu J; Nicoli S
    Sci Rep; 2016 Aug; 6():32386. PubMed ID: 27572667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR/Cas9 System to Knockdown MicroRNA In Vitro and In Vivo.
    Yi B; Larter K; Xi Y
    Methods Mol Biol; 2021; 2300():133-139. PubMed ID: 33792878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficiency of Recombinant CRISPR/rCas9-Mediated miRNA Gene Editing in Rice.
    Chung PJ; Chung H; Oh N; Choi J; Bang SW; Jung SE; Jung H; Shim JS; Kim JK
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox.
    Senís E; Fatouros C; Große S; Wiedtke E; Niopek D; Mueller AK; Börner K; Grimm D
    Biotechnol J; 2014 Nov; 9(11):1402-12. PubMed ID: 25186301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic applications and therapeutic option of Cascade CRISPR/Cas in the modulation of miRNA in diverse cancers: promises and obstacles.
    Alinejad T; Modarressi S; Sadri Z; Hao Z; Chen CS
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):9557-9575. PubMed ID: 37222810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges.
    Hussen BM; Rasul MF; Abdullah SR; Hidayat HJ; Faraj GSH; Ali FA; Salihi A; Baniahmad A; Ghafouri-Fard S; Rahman M; Glassy MC; Branicki W; Taheri M
    Mil Med Res; 2023 Jul; 10(1):32. PubMed ID: 37460924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo CRISPR screening for phenotypic targets of the
    Yang B; Schwartz M; McJunkin K
    Genes Dev; 2020 Sep; 34(17-18):1227-1238. PubMed ID: 32820039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.
    Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ
    mBio; 2018 Dec; 9(6):. PubMed ID: 30514786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis.
    Chambers C; Quan L; Yi G; Esquela-Kerscher A
    J Vis Exp; 2022 Apr; (182):. PubMed ID: 35532260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRISPR/Cas9-Based Genome Editing of Transcription Factor Genes in Marchantia polymorpha.
    Sugano SS; Nishihama R
    Methods Mol Biol; 2018; 1830():109-126. PubMed ID: 30043367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential pitfalls of CRISPR/Cas9-mediated genome editing.
    Peng R; Lin G; Li J
    FEBS J; 2016 Apr; 283(7):1218-31. PubMed ID: 26535798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR-Cas9 systems: versatile cancer modelling platforms and promising therapeutic strategies.
    Wen WS; Yuan ZM; Ma SJ; Xu J; Yuan DT
    Int J Cancer; 2016 Mar; 138(6):1328-36. PubMed ID: 26044706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knocking Out MicroRNA Genes in Rice with CRISPR-Cas9.
    Zhou J; Zhong Z; Chen H; Li Q; Zheng X; Qi Y; Zhang Y
    Methods Mol Biol; 2019; 1917():109-119. PubMed ID: 30610632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting miRNAs with CRISPR/Cas9 to Improve Recombinant Protein Production of CHO Cells.
    Kellner K; Solanki A; Amann T; Lao N; Barron N
    Methods Mol Biol; 2018; 1850():221-235. PubMed ID: 30242690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRISPR/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo.
    Chang H; Yi B; Ma R; Zhang X; Zhao H; Xi Y
    Sci Rep; 2016 Feb; 6():22312. PubMed ID: 26924382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient Mutagenesis of Marek's Disease Virus-Encoded microRNAs Using a CRISPR/Cas9-Based Gene Editing System.
    Luo J; Teng M; Zai X; Tang N; Zhang Y; Mandviwala A; Reddy VRAP; Baigent S; Yao Y; Nair V
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32325942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A stable but reversible integrated surrogate reporter for assaying CRISPR/Cas9-stimulated homology-directed repair.
    Wen Y; Liao G; Pritchard T; Zhao TT; Connelly JP; Pruett-Miller SM; Blanc V; Davidson NO; Madison BB
    J Biol Chem; 2017 Apr; 292(15):6148-6162. PubMed ID: 28228480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.